Oliver Gautschi Selected Research

Oliver Gautschi Research Topics

Disease

35	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 10/2004
34	Neoplasms (Cancer) 10/2023 - 10/2004
24	Lung Neoplasms (Lung Cancer) 06/2023 - 03/2006
9	Adenocarcinoma of Lung 01/2020 - 07/2012
8	Disease Progression 01/2020 - 04/2009
4	Malignant Mesothelioma 12/2023 - 12/2015
4	Carcinoma (Carcinomatosis) 03/2011 - 04/2008
3	Hypertension (High Blood Pressure) 01/2020 - 01/2020
3	Sarcoma (Soft Tissue Sarcoma) 04/2018 - 01/2013
2	Neoplasm Metastasis (Metastasis) 12/2021 - 10/2020
2	Hyponatremia 01/2020 - 01/2020
2	medullary Thyroid cancer 01/2020 - 01/2020
2	Brain Neoplasms (Brain Tumor) 10/2018 - 01/2017
2	Adenocarcinoma 04/2018 - 02/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2018 - 02/2011
2	Nausea 12/2015 - 01/2012
2	Vomiting 12/2015 - 01/2012
2	Mesothelioma 09/2007 - 09/2006
1	Bone Resorption 10/2020
1	Neutropenia 01/2020
1	Febrile Neutropenia 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Diarrhea 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Fibrosarcoma 04/2018
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 02/2018
1	Skin Neoplasms (Skin Cancer) 02/2018
1	Melanoma (Melanoma, Malignant) 02/2018
1	Respiratory Insufficiency (Respiratory Failure) 01/2017
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2017
1	Stroke (Strokes) 01/2017
1	Thymoma (Thymic Carcinoma) 12/2016

Drug/Important Bio-Agent (IBA)

9	ErbB Receptors (EGF Receptor)IBA 09/2023 - 02/2007
8	PlatinumIBA 12/2023 - 03/2006
7	Bevacizumab (Avastin)FDA Link 12/2023 - 12/2012
7	Anaplastic Lymphoma KinaseIBA 01/2020 - 01/2013
7	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2013
6	Pemetrexed (MTA)FDA Link 12/2023 - 03/2011
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017 - 12/2012
6	CrizotinibIBA 01/2017 - 01/2013
6	src-Family KinasesIBA 01/2017 - 05/2006
5	selpercatinibIBA 10/2023 - 01/2020
5	Docetaxel (Taxotere)FDA Link 01/2020 - 02/2011
5	Biomarkers (Surrogate Marker)IBA 07/2013 - 01/2008
4	LigandsIBA 10/2020 - 02/2014
3	Phosphotransferases (Kinase)IBA 10/2023 - 03/2008
3	Circulating Tumor DNAIBA 09/2023 - 10/2019
3	osimertinibIBA 09/2023 - 04/2021
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2017
3	pembrolizumabIBA 07/2021 - 12/2016
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2011
3	vandetanib (ZD6474)IBA 01/2020 - 05/2013
3	saracatinibIBA 02/2014 - 04/2008
2	NivolumabIBA 12/2023 - 02/2018
2	B7-H1 AntigenIBA 01/2023 - 07/2021
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2017
2	capmatinibIBA 04/2021 - 01/2020
2	RamucirumabIBA 01/2020 - 01/2018
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020 - 01/2020
2	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2020
2	cabozantinibIBA 01/2020 - 10/2018
2	Cell-Free Nucleic AcidsIBA 10/2019 - 10/2004
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2018 - 10/2018
2	Monoclonal AntibodiesIBA 01/2018 - 09/2007
2	VaccinesIBA 01/2018 - 02/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015 - 01/2013
2	Gefitinib (Iressa)FDA Link 01/2015 - 01/2013
2	VemurafenibIBA 11/2013 - 10/2012
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2007
2	Aurora KinasesIBA 03/2008 - 09/2006
2	DNA (Deoxyribonucleic Acid)IBA 09/2007 - 10/2004
2	Cyclin D1IBA 01/2007 - 03/2006
1	1-methyl-1-piperidinomethane sulfonateIBA 12/2023
1	IpilimumabIBA 12/2023
1	Protein Isoforms (Isoforms)IBA 06/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	trametinibIBA 12/2021
1	binimetinibIBA 01/2021
1	Zoledronic Acid (Zometa)FDA Link 10/2020
1	Denosumab FDA Link 10/2020
1	NF-kappa B (NF-kB)IBA 10/2020
1	SolventsIBA 01/2020
1	AfatinibIBA 01/2019
1	Sunitinib (Sutent)FDA Link 10/2018
1	human ERBB2 proteinIBA 04/2018
1	Death Domain ReceptorsIBA 02/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 11/2017
1	ponatinibIBA 01/2017
1	ceritinibIBA 01/2017

Therapy/Procedure

28	Therapeutics 06/2023 - 05/2006
14	Drug Therapy (Chemotherapy) 01/2022 - 10/2004
5	Immunotherapy 01/2023 - 02/2008
2	Neoadjuvant Therapy 12/2015 - 09/2015
2	Radiotherapy 12/2015 - 09/2015
1	Salvage Therapy 04/2021
1	Pneumonectomy (Lung Volume Reduction) 12/2015